Mahmut Muslumanoglu

Mahmut Muslumanoglu

Auto-generated profile, based on publicly available information

Mahmut Muslumanoglu

Breast Unit Department of General Surgery Istanbul Faculty of Medicine Istanbul University Istanbul Türkiye

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 April 2009 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
VÖVahit Özmen
Vahit Özmen
BOBeyza Ozcinar
Beyza Ozcinar
HKHasan Karanlik
Hasan Karanlik
NCNeslihan Cabioglu
Neslihan Cabioglu
MTMustafa Tukenmez
Mustafa Tukenmez
ASAtilla Soran
Atilla Soran
Breast cancer has been increased in developing countries, but there are limited data for breast cancer risk factors in these countries. To clarify the risk for breast cancer among the Turkish women, an university hospital based nested case-control study was conducted. Between January 2000 and December 2006, a survey was prospectively conducted among women admitted to clinics of Istanbul Medical Faculty for examination and/or treatment by using a questionnaire. Therefore, characteristics of patients diagnosed with breast cancer (n = 1492) were compared with control cases (n = 2167) admitted to hospital for non-neoplastic, non-hormone related diseases. Breast cancer risk was found to be increased in women with age (≥ 50) [95% confidence interval (CI) 2.42–3.18], induced abortion (95% CI 1.13–1.53), age at first birth (≥ 35) (95% CI 1.62–5.77), body mass index (BMI ≥ 25) (95% CI 1.27–1.68), and a positive family history (95% CI 1.11–1.92). However, decreased breast cancer risk was associated with the duration of education (≥ 13 years) (95% CI 0.62–0.81), presence of spontaneous abortion (95% CI 0.60–0.85), smoking (95% CI 0.61–0.85), breast feeding (95% CI 0.11–0.27), nulliparity (95% CI 0.92–0.98), hormone replacement therapy (HRT) (95% CI 0.26–0.47), and oral contraceptive use (95% CI 0.50–0.69). On multivariable logistic regression analysis, age (≥ 50) years (OR 2.61, 95% CI 2.20–3.11), induced abortion (OR 1.66, 95% CI 1.38–1.99), and oral contraceptive use (OR 0.60, 95% CI 0.48–0.74) were found to be associated with breast cancer risk as statistically significant independent factors. These findings suggest that age and induced abortion were found to be significantly associated with increased breast cancer risk whereas oral contraceptive use was observed to be associated with decreased breast cancer risk among Turkish women in Istanbul.

20 May 2016 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
ASAtilla Soran
Atilla Soran
VOVahit Ozmen
Vahit Ozmen
SOSERDAR OZBAS
SERDAR OZBAS
HKHasan Karanlik
Hasan Karanlik
MMMahmut Muslumanoglu
Mahmut Muslumanoglu
BLBarry C. Lembersky
Barry C. Lembersky
1005 Background: The MF07-01 trial is a multicenter phase III randomized trial of treatment naive stage IV BC patients comparing loco-regional surgery (LRS) followed by appropriate systemic therapy (ST) vs ST alone. Aims: To compare 3-year survival and loco-regional progression (LRP). Methods: At initial diagnosis patients were randomized 1:1 to LRS group or ST group. After consideration of retrospective studies, we hypothesized at 36 months a survival difference between the two groups to be 18%. Assuming a 10% drop out rate and with a one sided log-rank test with a 95% CI and a 90% power 271 patients needed to be randomized. Results: 274 patients were accrued; 138 in the LRS group and 136 in the ST group. The groups were comparable regarding age, BMI, HER2 neu, tumor type and size, histologic grade, and bone and visceral metastasis (all p > 0.05). There were 76 (55%) deaths in the LRS group and 101 (74%) in the ST group during the median 40 (20-51) months follow-up. At 36 months the survival rate was similar the LRS group and the ST group (60% and 51%, respectively; p = 0.5). Overall survival (OS) was 34% higher in the LRS group compared to the ST group (HR: 0.66, 95%CI 0.49-0.88: p = 0.005). In unplanned subgroup analyses, OS was statistically higher in LRS group than ST group; ER/PR (+) (HR: 0.64, 0.46-0.91, p = 0.01), HER2 neu (-) (HR: 0.64, 95%CI 0.45-0.91; p = 0.01), patients < 55 years (HR: 95%CI 0.57, 0.38-0.86; p = 0.006), and solitary bone only metastasis (HR: 0.47, 95%CI 0.23-0.98; p = 0.04). The median survival was 14 months higher in the LRS group comparing with the ST group in bone only metastasis (56 vs 42 months, respectively; HR 0.67, 95%CI 0.43-1.07; p = 0.09). LRP was 1% (n = 2) in the LRS group and it was 11% (n = 15) in the ST group (p = 0.001). Conclusion: In this trial we did not observe improvement in 36 month survival with surgery. However, longer follow up revealed statistically significant improvement in median survival with surgery (46 vs.37 months) at median 40 months follow up. Additionally, patients with a more indolent form of metastatic BC such as ER (+), HER2 neu (-), solitary bone metastasis, and patients < 55 years old have a significant survival benefit with initial surgery. Clinical trial information: NCT00557986.

27 February 2013 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
GCGokhan Cipe
Gokhan Cipe
NENurhan Ergul
Nurhan Ergul
MHMustafa Hasbahceci
Mustafa Hasbahceci
YFYurdakul Deniz Firat
Yurdakul Deniz Firat
SBSuleyman Bozkurt
Suleyman Bozkurt
MMMahmut Muslumanoglu
Mahmut Muslumanoglu
The use of positron emission tomography-computed tomography (PET/CT) for the preoperative staging of patients with colon and rectal cancer has increased steadily over the last decade. The aim of this study was to evaluate the effect of PET/CT on the preoperative staging and clinical management of patients with colorectal cancer.

1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
Handan TokmakHandan Tokmak
Handan Tokmak
KKKerim Kaban
Kerim Kaban
MMMahmut Muslumanoglu
Mahmut Muslumanoglu
MDMeral Demirel
Meral Demirel
SASukru Aktan
Sukru Aktan
In patients with recurrent or second primary ipsilateral breast cancer, axillary staging is the key factor in locoregional control and a strong prognostic characteristic. The efficient evaluation of lymphatic drainage of re-sentinel lymph node biopsies (re-SLNBs) has remained a challenge in the management of ipsilateral primary or recurrent breast cancer patients who are clinically lymph node negative. This study explores whether a SLNB for patients with primary or recurrent breast cancer is possible after previous axillary surgery. It evaluates potential reasons for mapping failure that might be associated with patients in this group.
1

13 November 2012 in Thyroid Research
Verified
Journal Article
Open access
PDF file
SSSerkan Sari
Serkan Sari
EAErhan Aysan
Erhan Aysan
MMMahmut Muslumanoglu
Mahmut Muslumanoglu
YEYeliz E Ersoy
Yeliz E Ersoy
HBHuseyin Bektasoglu
Huseyin Bektasoglu
EYErkan Yardimci
Erkan Yardimci
Background: We aimed to minimalize operative complications by spraying of methylene blue stain on thyroid glands and the perithyroidal area.Material and methods: The intra-operative methylene blue spraying technique was used prospectively on a total of 56 patients who had undergone primary (not recurrent) thyroid surgery for a variety of thyroid diseases. Bilateral total thyroidectomy was performed in all cases. After superior but before inferior pole ligation, 0.5ml of methylene blue was sprayed over the thyroid lobe and perilober area. Tissues, especially parathyroides, the recurrent laryngeal nerve, and the inferior thyroid artery, were identified and evaluated.Results: Recurrent laryngeal nerve and arteries were not stained and thus they remained white in all cases while all other tissues were stained blue. Within three minutes parathyroid glands washed out the blue stain and the original yellow color was regained. Thyroid tissue wash-out time was not less than 15 minutes; perithyroideal muscles, tendinous and lipoid structures took no less than 25 minutes.Conclusion: The safety of intravascular methylene blue guidance on thyroid surgery is known. This research demonstrates the effectiveness of the spraying technique, a new technique which ensures not only identification of parathyroid glands within three minutes, but also identification of recurrent laryngeal nerves and inferior thyroid arteries.

1 January 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
HKHUSEYIN KADIOGLU
HUSEYIN KADIOGLU
SOSERDAR OZBAS
SERDAR OZBAS
AAAlper Akcan
Alper Akcan
ASAykut Soyder
Aykut Soyder
LSLutfi Soylu
Lutfi Soylu
MMMahmut Müslümanoğlu
Mahmut Müslümanoğlu
Multiple breast cancers may present with different clinical and biological characteristics. The data indicate that multifocal (MF), multicentric (MC), and bilateral synchronous (BS) breast cancers (BC) are more aggressive and have an equivalent or moderately poorer survival rate compared with unilateral cases. However, a comparison of these multiple breast cancers has not been covered in the literature. The aim of this study was to describe the histopathological characteristics of patients suffering from MF, MC, and BS breast carcinoma and to compare their prognoses. Retrospective data for MF, MC, and BS breast carcinoma patients treated in five different breast cancer units in Turkey between 2003 and 2012 were collected. MF and MC cancers were defined as more than one lesion in the same quadrant or in separate quadrants, respectively. There were 507 patients (271 MF, 147 MC, and 89 BS) treated in this time period. BS breast carcinoma patients were younger than the other groups (44.83 ± 9.6, 47.27 ± 11.6, and 51.11 ± 11.8 years for BS, MF, and MC breast carcinoma patients, respectively). MFBC and MCBC patients in this study were younger than the ages reported in Western literature, but this result was similar to the ages reported in Eastern literature. The five-year survival rates and recurrence rates were not statistically different among groups (P = 0.996 and P = 0.263, respectively). According to univariate analyses, tumor size, histological grade, and lymph node status were statistically significant factors that affected survival. However, only lymph node involvement was significant for survival according to multivariate analyses. The clinical significance of MF, MC, and BS breast cancers is still unclear and their influence on prognosis is controversial. Disease-free and overall survival rates of BS breast cancers might be similar to MF and MC breast cancers.